Cyclo Therapeutics Announces Execution Of Definitive Agreement With Rafael Holdings, Inc. Providing For $5.0 Million Of Additional Funding Via A Private Placement
Round Type
Post-IPO Equity
GainesvilleBiotechnologyHealth CareTherapeuticsInvestors
Description
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that it has entered into a binding agreement with Rafael Holdings, Inc. (NYSE:RFL) (“Rafael”) under which Rafael has agreed to purchase 4,000,000 shares of common stock of Cyclo Therapeutics and warrants to purchase an additional 4,000,000 shares of common stock of Cyclo Therapeutics, for an aggregate purchase price of $5,000,000. The warrants will have an exercise price of $1.25 and a term of seven years
Quick answer
Cyclo Therapeutics raised an undisclosed amount in a Post-IPO Equity round, dated June 5, 2023. Investors: Rafael and Rafael Holdings. Cyclo Therapeutics is based in Gainesville, Florida, United States.
- How much did Cyclo Therapeutics raise?
- Cyclo Therapeutics raised an undisclosed amount in a Post-IPO Equity round on June 5, 2023.
- Who invested in Cyclo Therapeutics?
- Rafael and Rafael Holdings are named as investors in this round.
- What does Cyclo Therapeutics do?
- Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life- changing medicines through science and innovation for patients and families living with disease.
- Where is Cyclo Therapeutics based and how big is it?
- Cyclo Therapeutics is based in Gainesville, Florida, United States.
- Who are the decision-makers at Cyclo Therapeutics?
- Fundz holds 1 contact at Cyclo Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Cyclo Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- KayoThera, Inc. raised an undisclosed amount (Series A) on July 19, 2023.
- SURGE Therapeutics raised $32M (Series B) on July 19, 2023.
- Renibus Therapeutics raised $47M (Funding Round) on July 18, 2023.
- Tenpoint Therapeutics raised $70M (Series A) on July 12, 2023.
- Smartlens raised $6.1M (Series A) on July 11, 2023.
- TolerogenixX raised $13M (Series A) on July 6, 2023.
Who to call at Cyclo Therapeutics, and when
A new round usually means Cyclo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cyclo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cyclo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cyclo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cyclo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cyclo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.